Viewing Study NCT00865566


Ignite Creation Date: 2025-12-24 @ 4:38 PM
Ignite Modification Date: 2026-01-18 @ 10:55 PM
Study NCT ID: NCT00865566
Status: TERMINATED
Last Update Posted: 2021-10-15
First Post: 2009-03-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-05
Start Date Type: None
Primary Completion Date: 2017-10-06
Primary Completion Date Type: ACTUAL
Completion Date: 2017-10-06
Completion Date Type: ACTUAL
First Submit Date: 2009-03-17
First Submit QC Date: None
Study First Post Date: 2009-03-19
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-10-08
Results First Submit QC Date: None
Results First Post Date: 2019-02-27
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-10-13
Last Update Post Date: 2021-10-15
Last Update Post Date Type: ACTUAL